Literature DB >> 21691120

Hypoxia does neither stimulate pulmonary artery endothelial cell proliferation in mice and rats with pulmonary hypertension and vascular remodeling nor in human pulmonary artery endothelial cells.

Lunyin Yu1, Charles A Hales.   

Abstract

BACKGROUND: Hypoxia results in pulmonary hypertension and vascular remodeling due to induction of pulmonary artery cell proliferation. Besides pulmonary artery smooth muscle cells, pulmonary artery endothelial cells (PAECs) are also involved in the development of pulmonary hypertension, but the effect of hypoxia on PAEC proliferation has not been completely understood.
METHODS: We investigated PAEC proliferation in mice and rats with hypoxia-induced pulmonary hypertension and vascular remodeling as well as in human PAECs under hypoxia. RESULTS AND
CONCLUSION: We did not find significant PAEC proliferation in chronically hypoxic rats or mice. There was a slight decrease in proliferation in mice and rats with pulmonary hypertension and vascular remodeling. We also did not find significant human PAEC proliferation and cell cycle progression under different levels of oxygen (1, 2, 3, 5 and 10%) for one day, although the same conditions of hypoxia induced significant proliferation and cell cycle progression in pulmonary artery smooth muscle cells and pulmonary artery fibroblasts. Exposure to hypoxia for 7 days also did not increase PAEC proliferation. These results demonstrated that hypoxia alone is not a stimulus to PAEC proliferation in vivo and in vitro. The present study provides a novel role for PAECs in hypoxia-induced pulmonary hypertension and vascular remodeling.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21691120      PMCID: PMC3128130          DOI: 10.1159/000327005

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  46 in total

Review 1.  Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension.

Authors:  T K Jeffery; J C Wanstall
Journal:  Pharmacol Ther       Date:  2001-10       Impact factor: 12.310

Review 2.  The pathobiology of pulmonary hypertension. Endothelium.

Authors:  R M Tuder; C D Cool; M Yeager; L Taraseviciene-Stewart; T M Bull; N F Voelkel
Journal:  Clin Chest Med       Date:  2001-09       Impact factor: 2.878

3.  Expression of vascular endothelial growth factor and its receptors correlates closely with formation of the plexiform lesion in human pulmonary hypertension.

Authors:  S Hirose; Y Hosoda; S Furuya; T Otsuki; E Ikeda
Journal:  Pathol Int       Date:  2000-06       Impact factor: 2.534

4.  Distinct patterns of circulating endothelial cells in pulmonary hypertension.

Authors:  D M Smadja; L Mauge; O Sanchez; J-S Silvestre; C Guerin; A Godier; P Henno; P Gaussem; D Israël-Biet
Journal:  Eur Respir J       Date:  2010-04-22       Impact factor: 16.671

5.  Pulmonary vascular remodelling in hypoxic rats: effects of amlodipine, alone and with perindopril.

Authors:  T K Jeffery; J C Wanstall
Journal:  Eur J Pharmacol       Date:  2001-03-23       Impact factor: 4.432

6.  Transplantation of endothelial progenitor cells into the lung to alleviate pulmonary hypertension in dogs.

Authors:  Mitsuru Takahashi; Tatsuo Nakamura; Toshinari Toba; Naohiro Kajiwara; Harubumi Kato; Yasuhiko Shimizu
Journal:  Tissue Eng       Date:  2004 May-Jun

7.  Effect of heparin and warfarin on chronic hypoxic pulmonary hypertension and vascular remodeling in the guinea pig.

Authors:  P M Hassoun; B T Thompson; D Steigman; C A Hales
Journal:  Am Rev Respir Dis       Date:  1989-03

8.  Impairment of hypoxic pulmonary artery remodeling by heparin in mice.

Authors:  C A Hales; R L Kradin; R D Brandstetter; Y J Zhu
Journal:  Am Rev Respir Dis       Date:  1983-10

9.  Hypoxia increases AP-1 binding activity by enhancing capacitative Ca2+ entry in human pulmonary artery endothelial cells.

Authors:  Ivana Fantozzi; Shen Zhang; Oleksandr Platoshyn; Carmelle V Remillard; Randy T Cowling; Jason X-J Yuan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-08-08       Impact factor: 5.464

10.  A NHERF binding site links the betaPDGFR to the cytoskeleton and regulates cell spreading and migration.

Authors:  Marianne F James; Roberta L Beauchamp; Nitasha Manchanda; Andrius Kazlauskas; Vijaya Ramesh
Journal:  J Cell Sci       Date:  2004-05-25       Impact factor: 5.285

View more
  19 in total

Review 1.  A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.

Authors:  Jose Gomez-Arroyo; Sheinei J Saleem; Shiro Mizuno; Aamer A Syed; Harm J Bogaard; Antonio Abbate; Laimute Taraseviciene-Stewart; Yon Sung; Donatas Kraskauskas; Daniela Farkas; Daniel H Conrad; Mark R Nicolls; Norbert F Voelkel
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-02-03       Impact factor: 5.464

2.  Nestin-expressing vascular wall cells drive development of pulmonary hypertension.

Authors:  Farhan Saboor; Ansgar N Reckmann; Claudia U M Tomczyk; Dorothea M Peters; Norbert Weissmann; Andre Kaschtanow; Ralph T Schermuly; Tatyana V Michurina; Grigori Enikolopov; Dieter Müller; Andrea Mietens; Ralf Middendorff
Journal:  Eur Respir J       Date:  2015-12-23       Impact factor: 16.671

3.  Iptakalim ameliorates hypoxia-impaired human endothelial colony-forming cells proliferation, migration, and angiogenesis via Akt/eNOS pathways.

Authors:  Mengyu He; Ting Cui; Qing Cai; Hong Wang; Hui Kong; Weiping Xie
Journal:  Pulm Circ       Date:  2019-10-18       Impact factor: 3.017

Review 4.  NADPH oxidases-do they play a role in TRPC regulation under hypoxia?

Authors:  Monika Malczyk; Christine Veith; Ralph T Schermuly; Thomas Gudermann; Alexander Dietrich; Natascha Sommer; Norbert Weissmann; Oleg Pak
Journal:  Pflugers Arch       Date:  2015-10-01       Impact factor: 3.657

5.  Lung Angiogenesis Requires CD4(+) Forkhead Homeobox Protein-3(+) Regulatory T Cells.

Authors:  Franco R D'Alessio; Qiong Zhong; John Jenkins; Aigul Moldobaeva; Elizabeth M Wagner
Journal:  Am J Respir Cell Mol Biol       Date:  2015-05       Impact factor: 6.914

6.  Silencing of sodium-hydrogen exchanger 1 attenuates the proliferation, hypertrophy, and migration of pulmonary artery smooth muscle cells via E2F1.

Authors:  Lunyin Yu; Charles A Hales
Journal:  Am J Respir Cell Mol Biol       Date:  2011-03-31       Impact factor: 6.914

7.  Differential regulation of pulmonary vascular cell growth by hypoxia-inducible transcription factor-1α and hypoxia-inducible transcription factor-2α.

Authors:  Aftab Ahmad; Shama Ahmad; Kenneth C Malcolm; Stacy M Miller; Tara Hendry-Hofer; Jerome B Schaack; Carl W White
Journal:  Am J Respir Cell Mol Biol       Date:  2013-07       Impact factor: 6.914

8.  Proteasome inhibitor PS-341 attenuates flow-induced pulmonary arterial hypertension.

Authors:  Ya-Yun Wang; Yun Luan; Xue Zhang; Mei Lin; Zhao-Hua Zhang; Xiao-Bo Zhu; Yu Ma; Yi-Biao Wang
Journal:  Clin Exp Med       Date:  2013-06-16       Impact factor: 3.984

Review 9.  The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes.

Authors:  Steven C Pugliese; Jens M Poth; Mehdi A Fini; Andrea Olschewski; Karim C El Kasmi; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-11-21       Impact factor: 5.464

10.  MicroRNA-21 is Associated with the Severity of Right Ventricular Dysfunction in Patients with Hypoxia-Induced Pulmonary Hypertension.

Authors:  Wei-Ting Chang; Chih-Hsin Hsu; Tzu-Ling Huang; Ying-Ching Tsai; Chun-Yen Chiang; Zhih-Cherng Chen; Jhih-Yuan Shih
Journal:  Acta Cardiol Sin       Date:  2018-11       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.